Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children

Current Medical Research and Opinion

Volumn 26, Issue 9, 2010, Pages 2175-2181

  Welliver Sr , Robert C ^a   Checchia, Paul A ^b   Bauman, Jay H ^c   Fernandes, Ancilla W ^d   Mahadevia, Parthiv J ^d   Hall, Caroline B ^e  

^a UNIVERSITY AT BUFFALO   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

^c Scientific and Technical Evaluation of Pharmaceuticals Inc   (United States)

^d MEDIMMUNE   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Mortality, infant; Postneonatal mortality; Respiratory syncytial virus infections; Respiratory syncytial virus, human; Respiratory syncytial viruses; Respiratory tract infections

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; PALIVIZUMAB; PLACEBO; RIBAVIRIN;

ADVERSE OUTCOME; ANTIVIRAL THERAPY; ARTIFICIAL VENTILATION; BRONCHOPNEUMONIA; CAUSE OF DEATH; CHILD HOSPITALIZATION; CHILDHOOD LEUKEMIA; CHRONIC DISEASE; CLINICAL TRIAL; COMORBIDITY; CONGENITAL HEART DISEASE; CORTICOSTEROID THERAPY; DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; FATALITY; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOPROPHYLAXIS; INFECTION RISK; INTENSIVE CARE; LUNG DISEASE; LUNG DYSPLASIA; LUNG TUBERCULOSIS; MALARIA; MALNUTRITION; MEASLES; MEDLINE; META ANALYSIS; MYOPATHY; NEUROMUSCULAR DISEASE; PEDIATRIC ADVANCED LIFE SUPPORT; PNEUMONIA; PREMATURITY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; RISK FACTOR; SEPTICEMIA; SPINAL MUSCULAR ATROPHY; SYSTEMATIC REVIEW; VIRAL BRONCHIOLITIS;

CHILD MORTALITY; CHILD, PRESCHOOL; HEALTH; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; PUBLICATIONS; RESEARCH REPORT; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES;

EID: 77955600570     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.505126     Document Type: Review

References (52)

1. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003;143:S127-32
2. McLaurin K, Leader S. Growing impact of RSV hospitalizations among infants in the US, 1997-20. Pediatric Academic Societies' Meeting; 2005 May 14-17; Washington, DC
3. McLaurin KK, Hall CB, Jackson EA, et al. Persistence of morbidity and cost differences between late-preterm and term infants during the first year of life. Pediatrics 2009;123:653-659
4. Iwane MK, Edwards KM, Szilagyi PG, et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004;113:1758-1764
5. Diez Domingo J, Ridao Lopez M, Ubeda Sansano I, et al. [Incidence and cost of hospitalizations for bronchiolitis and respiratory syncytial virus infections in the autonomous community of Valencia in Spain (2001 and 2002)]. An Pediatr (Barc) 2006;65:325-330
6. Howard TS, Hoffman LH, Stang PE, et al. Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality. J Pediatr 2000;137:227-232
7. Paramore LC, Ciuryla V, Ciesla G, et al. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics 2004;22:275-284
8. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009;360:588-598
9. Bourgeois FT, Valim C, McAdam AJ, et al. Relative impact of influenza and respiratory syncytial virus in young children. Pediatrics 2009;124:e1072-80
10. Respiratory syncytial virus. In: Pickering LK, ed. Red Book: 2006 Report of the Committee on Infectious Diseases. 29th edn. Elk Grove Village, IL: American Academy of Pediatrics, 2009:560-569
11. Anderson LJ, Parker RA, Strikas RL. Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children. J Infect Dis 1990;161:640-646
12. Fleming DM, Pannell RS, Cross KW. Mortality in children from influenza and respiratory syncytial virus. J Epidemiol Community Health 2005;59:586-590
13. Shay DK, Holman RC, Roosevelt GE, et al. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-19. J Infect Dis 2001;183:16-22
14. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-186 (Pubitemid 36068705)
15. Berger TM, Aebi C, Duppenthaler A, et al. Prospective population-based study of RSV-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001-2005). Infection 2009;37:109-116
16. Chidekel AS, Rosen CL, Bazzy AR. Rhinovirus infection associated with serious lower respiratory illness in patients with bronchopulmonary dysplasia. Pediatr Infect Dis J 1997;16:43-47
17. Hall CB, Kopelman AE, Douglas Jr RG, et al. Neonatal respiratory syncytial virus infection. N Engl J Med 1979;300:393-396
18. Jamjoom GA, al-Semrani AM, Board A, et al. Respiratory syncytial virus infection in young children hospitalized with respiratory illness in Riyadh. J Trop Pediatr 1993;39:346-349
19. Kanra G, Tezcan S, Yilmaz G. Respiratory syncytial virus epidemiology in Turkey. Turk J Pediatr 2005;47:303-308
20. Navas L, Wang E, de Carvalho V, et al. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr 1992;121:348-354
21. Simon A, Ammann RA, Wilkesmann A, et al. Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database. Eur J Pediatr 2007;166:1273-1283
22. Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child 2009;94:99-103
23. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995;126:212-219
24. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998; 102:531-537
25. Buckingham SC, Quasney MW, Bush AJ, et al. Respiratory syncytial virus infections in the pediatric intensive care unit: clinical characteristics and risk factors for adverse outcomes. Pediatr Crit Care Med 2001;2:318-323
26. Feltes TF, Cabalka AK, Meissner HC, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 2003;143:532-540
27. Kristensen K, Dahm T, Frederiksen PS, et al. Epidemiology of respiratory syncytial virus infection requiring hospitalization in East Denmark. Pediatr Infect Dis J 1998;17:996-1000
28. Lee JT, Chang LY, Wang LC, et al. Epidemiology of respiratory syncytial virus infection in northern Taiwan, 2001-2005-seasonality, clinical characteristics, and disease burden. J Microbiol Immunol Infect 2007;40:293-301
29. MacDonald NE, Hall CB, Suffin SC, et al. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 1982;307:397-400
30. Moler FW, Khan AS, Meliones JN, et al. Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience. Crit Care Med 1992;20:1406-1413
31. Morrow BM, Hatherill M, Smuts HE, et al. Clinical course of hospitalised children infected with human metapneumovirus and respiratory syncytial virus. J Paediatr Child Health 2006;42:174-178
32. Carballal G, Videla CM, Espinosa MA, et al. Multicentered study of viral acute lower respiratory infections in children from four cities of Argentina, 1993-19. J Med Virol 2001;64:167-174
33. Carbonell-Estrany X, Quero J, Bustos G, et al. Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group. Pediatr Infect Dis J 2000;19:592-597
34. Deshpande SA, Northern V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch Dis Child 2003;88:1065-1069
35. Eriksson M, Bennet R, Rotzen-Ostlund M, et al. Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting. Acta Paediatr 2002;91:593-598
36. Hussey GD, Apolles P, Arendse Z, et al. Respiratory syncytial virus infection in children hospitalised with acute lower respiratory tract infection. S Afr Med J 2000;90:509-512
37. Sampalis JS. Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants. J Pediatr 2003;143:S150-6
38. Meert K, Heidemann S, Abella B, et al. Does prematurity alter the course of respiratory syncytial virus infection? Crit Care Med 1990;18:1357-1359
39. Wilkesmann A, Ammann RA, Schildgen O, et al. Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course. Pediatr Infect Dis J 2007; 26:485-491
40. Tsolia MN, Kafetzis D, Danelatou K, et al. Epidemiology of respiratory syncytial virus bronchiolitis in hospitalized infants in Greece. Eur J Epidemiol 2003;18:55-61
41. Thwaites R, Piercy J. Nosocomial respiratory syncytial virus infection in neonatal units in the United Kingdom. Acta Paediatr Suppl 2004;93:23-25
42. Chan PK, Sung RY, Fung KS, et al. Epidemiology of respiratory syncytial virus infection among paediatric patients in Hong Kong: seasonality and disease impact. Epidemiol Infect 1999;123:257-262
43. Langley JM, LeBlanc JC, Wang EE, et al. Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: a Pediatric Investigators Collaborative Network on Infections in Canada Study. Pediatrics 1997;100:943-946
44. Meyer TA, Warner BW. Extracorporeal life support for the treatment of viral pneumonia: collective experience from the ELSO registry. Extracorporeal Life Support Organization. J Pediatr Surg 1997;32:232-236
45. Avendano LF, Palomino MA, Larranaga C. Surveillance for respiratory syncytial virus in infants hospitalized for acute lower respiratory infection in Chile (1989 to 2000). J Clin Microbiol 2003;41:4879-4882
46. Abzug MJ, Beam AC, Gyorkos EA, et al. Viral pneumonia in the first month of life. Pediatr Infect Dis J 1990;9:881-885
47. Djelantik IG, Gessner BD, Soewignjo S, et al. Incidence and clinical features of hospitalization because of respiratory syncytial virus lower respiratory illness among children less than two years of age in a rural Asian setting. Pediatr Infect Dis J 2003;22:150-157
48. Hayes EB, Hurwitz ES, Schonberger LB, et al. Respiratory syncytial virus outbreak on American Samoa. Evaluation of risk factors. Am J Dis Child 1989;143:316-321
49. Loscertales MP, Roca A, Ventura PJ, et al. Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern Mozambique. Pediatr Infect Dis J 2002;21:148-155 (Pubitemid 34150614)
50. Videla C, Carballal G, Misirlian A, et al. Acute lower respiratory infections due to respiratory syncytial virus and adenovirus among hospitalized children from Argentina. Clin Diagn Virol 1998;10:17-23
51. Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980-19. JAMA 1999;282:1440-1446
52. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010;375: 1545-1555